Dr Reddy's launches Zoledronic Acid Injection in US market
Quotes

Dr Reddy's launches Zoledronic Acid Injection in US market

Last Updated: Tuesday, March 05, 2013, 16:03
 
 Comment 0
 
Dr Reddy's launches Zoledronic Acid Injection in US market
New Delhi: Drug firm Dr Reddy's Laboratories on Tuesday said it has launched generic Zoledronic Acid injection in the American market following approval by the US health regulator.

The company has launched Zoledronic Acid injection in the strength of 4mg/5mL following the approval of its abbreviated new drug application (ANDA) by the United States Food & Drug Administration (USFDA), the company said in a statement.

The product is a generic version of Novartis Oncology's Zometa (zoledronic acid) injection in the same strength.

Company's injection is available in a single use vial of concentrate, Dr Reddy's Laboratories said..
Zometa is used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer, as well as for treating osteoporosis.

Shares of Dr Reddy's Laboratories were today quoting at Rs 1,792.40 apiece on the BSE in the late afternoon trade, up 1.60 percent from their previous close.

PTI



First Published: Tuesday, March 05, 2013, 16:03


Comments


comments powered by Disqus
BMW-X3
BMW-X3
Forbes Best Places for Biz 2014
Forbes Best Places for Biz 2014
Hyundai Elite i20
Hyundai Elite i20
Honda Mobilio MPV
Honda Mobilio MPV
Tata Zest first drive review: In pics
Tata Zest first drive review: In pics

Web Wrap
Contact Us : Privacy Policy : Legal Disclaimer
Copyright © Zee Media Corporation Ltd. All rights reserved